Similar articles for PMID: 15985101

Year	Number of Results
1953	1
1954	2
1955	3
1956	1
1959	1
1965	1
1970	1
1978	1
1979	1
1983	3
1985	1
1986	1
1987	2
1989	3
1990	2
1993	6
1994	3
1995	2
1996	5
1997	4
1998	7
1999	7
2000	14
2001	6
2002	11
2003	10
2004	30
2005	37
2006	17
2007	24
2008	22
2009	17
2010	20
2011	12
2012	20
2013	19
2014	12
2015	17
2016	18
2017	17
2018	18
2019	18
2020	24
2021	25
2022	14
2023	4
2024	1

1

Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.

Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R. Jakubowski M, et al. Headache. 2005 Jul-Aug;45(7):850-61. doi: 10.1111/j.1526-4610.2005.05153.x. Headache. 2005. PMID: 15985101 Clinical Trial.

2

Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization.

Burstein R, Jakubowski M. Burstein R, et al. Ann Neurol. 2004 Jan;55(1):27-36. doi: 10.1002/ana.10785. Ann Neurol. 2004. PMID: 14705109

3

Clarification of developing and established clinical allodynia and pain-free outcomes.

Landy SH, McGinnis JE, McDonald SA. Landy SH, et al. Headache. 2007 Feb;47(2):247-52. doi: 10.1111/j.1526-4610.2006.00689.x. Headache. 2007. PMID: 17300364 Clinical Trial.

4

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

Burstein R, Collins B, Jakubowski M. Burstein R, et al. Ann Neurol. 2004 Jan;55(1):19-26. doi: 10.1002/ana.10786. Ann Neurol. 2004. PMID: 14705108

5

Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.

Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D. Mathew NT, et al. Headache. 2009 Jul;49(7):971-82. doi: 10.1111/j.1526-4610.2009.01458.x. Epub 2009 May 27. Headache. 2009. PMID: 19486178 Clinical Trial.

6

Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial.

Silberstein SD, Young WB, Hopkins MM, Gebeline-Myers C, Bradley KC. Silberstein SD, et al. Headache. 2007 Jun;47(6):878-85. doi: 10.1111/j.1526-4610.2007.00826.x. Headache. 2007. PMID: 17578539 Clinical Trial.

7

Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention.

Landy S, Hoagland R, Hoagland NA. Landy S, et al. Headache. 2012 Jan;52(1):133-9. doi: 10.1111/j.1526-4610.2011.01992.x. Epub 2011 Aug 29. Headache. 2012. PMID: 21883200 Clinical Trial.

8

Sumatriptan and naproxen sodium for the acute treatment of migraine.

Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ. Smith TR, et al. Headache. 2005 Sep;45(8):983-91. doi: 10.1111/j.1526-4610.2005.05178.x. Headache. 2005. PMID: 16109111 Clinical Trial.

9

Central sensitization theory of migraine: clinical implications.

Dodick D, Silberstein S. Dodick D, et al. Headache. 2006 Nov;46 Suppl 4:S182-91. doi: 10.1111/j.1526-4610.2006.00602.x. Headache. 2006. PMID: 17078850 Review.

10

Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion.

Jakubowski M, Levy D, Kainz V, Zhang XC, Kosaras B, Burstein R. Jakubowski M, et al. Neuroscience. 2007 Aug 24;148(2):573-83. doi: 10.1016/j.neuroscience.2007.04.064. Epub 2007 Jul 25. Neuroscience. 2007. PMID: 17651900 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

441 results

Results by year